Abstract:
Disclosed are an anti-idiotype antibody that specifically binds to an idiotope site of an anti-c-Met antibody, the use of the anti-idiotype antibody for detecting the anti-c-Met antibody, and methods, polypeptides, polynucleotides, compositions, and vaccines related thereto.
Abstract:
A polypeptide, an anti-VEGF antibody and an anti-c-Met/anti-VEGF bispecific antibody, which includes the polypeptide, a pharmaceutical composition including the antibody, and a method of treating cancer using the antibody.
Abstract:
A method for predicting and/or monitoring the efficacy of a c-Met inhibitor using a biomarker; a method for selecting a subject suitable for the application of a c-Met inhibitor using a biomarker; and a method for preventing and/or treating cancer comprising administering a c-Met inhibitor to the selected subject.
Abstract:
A method of configuring a network of a power transmitting unit (PTU) includes determining whether a neighboring PTU is operating in a master mode; determining an operation mode of a PTU based on a result of the determining; and setting a network between the PTU and the neighboring PTU based on the operation mode of the PTU.
Abstract:
A wireless power transmission apparatus for tracking a charging capacity of each of a plurality of wireless power reception apparatuses in an environment in which the plurality of wireless power reception apparatuses are charged includes a communication unit configured to receive information about either one or both of a charging support power and a requested power from each of the plurality of wireless power reception apparatuses, a controller configured to determine a charging capacity for a wireless power reception apparatus supporting the charging support power among the plurality of wireless power reception apparatuses based on the information about the charging support power, and a power tracker configured to re-track the determined charging capacity based on charging status information received from the plurality of wireless power reception apparatuses.
Abstract:
A method for predicting and/or monitoring the efficacy of a c-Met inhibitor using a biomarker; a method for selecting a subject suitable for the application of a c-Met inhibitor using a biomarker; and a method for preventing and/or treating cancer comprising administering a c-Met inhibitor to the selected subject.
Abstract:
A wireless power transmission apparatus for tracking a charging capacity of each of a plurality of wireless power reception apparatuses in an environment in which the plurality of wireless power reception apparatuses are charged includes a communication unit configured to receive information about either one or both of a charging support power and a requested power from each of the plurality of wireless power reception apparatuses, a controller configured to determine a charging capacity for a wireless power reception apparatus supporting the charging support power among the plurality of wireless power reception apparatuses based on the information about the charging support power, and a power tracker configured to re-track the determined charging capacity based on charging status information received from the plurality of wireless power reception apparatuses.
Abstract:
A biomarker for predicting and/or monitoring the efficacy of a c-Met inhibitor; a composition for predicting and/or monitoring the efficacy of a c-Met inhibitor, comprising a material detecting the biomarker; a composition for selecting a subject suitable for the application of a c-Met inhibitor, comprising a material detecting the biomarker; a method for predicting and/or monitoring the efficacy of a c-Met inhibitor using the biomarker; a method for selecting a subject suitable for the application of a c-Met inhibitor using the biomarker; and a method for preventing and/or treating cancer comprising administering a c-Met inhibitor to the selected subject.
Abstract:
A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met (hereinafter, ‘c-Met inhibitor’) and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met inhibitor.
Abstract:
A wireless power transmission apparatus for tracking a charging capacity of each of a plurality of wireless power reception apparatuses in an environment in which the plurality of wireless power reception apparatuses are charged includes a communication unit configured to receive information about either one or both of a charging support power and a requested power from each of the plurality of wireless power reception apparatuses, a controller configured to determine a charging capacity for a wireless power reception apparatus supporting the charging support power among the plurality of wireless power reception apparatuses based on the information about the charging support power, and a power tracker configured to re-track the determined charging capacity based on charging status information received from the plurality of wireless power reception apparatuses.